So we have people selling all day long at 52 week lows. No bad news, only positive indications like better treatment for cancer likely, effective treatment for long haulers eminent, HIV improved treatment, NASH treatment looking strong along with the CD16. . And we are at a little over a buck a share.
.

Someone is putting a lot of energy in keeping this drug down. For now.